ZLD Chart, page-629

To those who sell now, do you realize that this company is only 7 weeks from releasing its first revenue ever, transforming into a revenue generating company.

given its focus on research not manufacturing with a total wages bill less than 1.5 millions, it won’t take many quarters before it report a profit.

The green rush is back, imagine what will happen to a revenue generating stock with approved products in many countries.

i spoke to a friend who works for a big pharma in Switzerland, it was her first time hearing about Zelira, the first thing she said was “ it won’t be long before a big pharma acquire Zelira, big pharma pays 5-20 times the price of the current share. Usually on the higher side given IPs owned by Zelira.